DeuterOncology
PrivateLast Round
Grant
Apr 7, 2023
Total Funding Raised
$12.72M
Company Overview
DeuterOncology is a biotechnology company developing a deuterated MET kinase inhibitor as a targeted therapy for MET driven diseases, such as lung cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DeuterOncology Comps
Public and private peers based on sector, stage, and business model.
DeuterOncology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 7, 2023 | ||||
| Series A | Jan 19, 2023 | ||||
| Series A | Jan 19, 2023 | ||||
| Seed | Feb 24, 2021 |
Key People
Founding team and executive leadership
DeuterOncology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Public service of Wallonia | Grant |
| Newton Biocapital | Series A, Seed |
| Noshaq | Series A |
| Financière Spin-off Luxembourgeoise | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 8, 2025
Monthly visitors increased 677% MoM.
- Apr 7, 2023
$515K grant received from Public service of Wallonia.
DeuterOncology Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about DeuterOncology's valuation, stock price, and market status.
